Skip to content

Hany Aref

  • MD,FAAN
  • 2h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 14CitationsNumber of citations received by Hany's publications. Updated daily.

Other IDs

Co-authors (45)

Publications (5)

  • Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East

    • Achiron A
    • Aref H
    • Inshasi J
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt

    • Zakaria M
    • Zamzam D
    • Abdel Hafeez M
    • et al.
    N/AReaders
    2Citations
    Get full text
  • Real-world evaluation of compliance and preference in Alzheimer’s disease treatment

    • Pai M
    • Aref H
    • Bassil N
    • et al.
    N/AReaders
    2Citations
    Get full text
  • Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring

    • Alroughani R
    • Aref H
    • Bohlega S
    • et al.
    N/AReaders
    2Citations
    Get full text
  • Elevated serum Bcl-2 in children with temporal lobe epilepsy

    • Kilany A
    • Raouf E
    • Gaber A
    • et al.
    N/AReaders
    6Citations
    Get full text